tiprankstipranks
Restart Life Sciences (TSE:HEAL)
:HEAL
Canadian Market
HEAL
Restart Life Sciences
RESEARCH TOOLSreports
Want to see TSE:HEAL full AI Analyst Report?

Restart Life Sciences (HEAL) Ratios

10 Followers

Restart Life Sciences Ratios

TSE:HEAL's free cash flow for Q4 2025 was C$0.00. For the 2025 fiscal year, TSE:HEAL's free cash flow was decreased by C$ and operating cash flow was C$0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 3.67 3.67 0.37 0.02 1.11
Quick Ratio
 3.67 3.67 0.37 0.02 1.11
Cash Ratio
 3.33 3.33 0.02 <0.01 1.04
Solvency Ratio
 -2.89 -2.89 0.46 -1.45 -14.71
Operating Cash Flow Ratio
 -1.35 -1.49 -0.15 -0.33 -5.65
Short-Term Operating Cash Flow Coverage
 -2.65 -2.92 -0.90 0.00 0.00
Net Current Asset Value
C$ 1.28MC$ 1.28MC$ -308.14KC$ -821.99KC$ 27.02K
Leverage Ratios
Debt-to-Assets Ratio
 0.14 0.14 0.42 0.00 0.00
Debt-to-Equity Ratio
 0.19 0.19 -0.27 0.00 0.00
Debt-to-Capital Ratio
 0.16 0.16 -0.36 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.37 1.37 -0.64 -0.04 7.18
Debt Service Coverage Ratio
 -5.48 -5.48 -8.22 0.00 -2.42
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 -1.50
Debt to Market Cap
 0.07 0.06 0.09 0.00 0.00
Interest Debt Per Share
 0.02 <0.01 <0.01 0.00 <0.01
Net Debt to EBITDA
 1.01 1.01 -0.10 <0.01 0.14
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%152.52%
EBT Per EBIT
103.36%103.36%-34.13%99.37%127.18%
Return on Assets (ROA)
-78.69%-78.69%118.04%-3942.25%-1267.21%
Return on Equity (ROE)
-379.02%-108.04%-75.15%151.05%-9096.56%
Return on Capital Employed (ROCE)
-104.53%-104.53%220.19%152.01%-4689.63%
Return on Invested Capital (ROIC)
-87.79%-87.79%300.42%152.01%-4689.63%
Return on Tangible Assets
-78.69%-78.69%118.04%-3942.25%-1267.21%
Earnings Yield
-43.18%-32.82%24.50%-4.17%-2.75%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 0.00 0.00 0.00 <0.01 0.03
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 0.00 0.00 0.00 -48.01K -11.44K
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 0.00 48.01K 11.44K
Operating Cycle
 0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.04 -0.02 >-0.01 >-0.01 -0.01
Free Cash Flow Per Share
 -0.04 -0.02 >-0.01 >-0.01 -0.01
CapEx Per Share
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 -2.65 -2.92 -0.90 0.00 0.00
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-18.71%-16.93%-7.83%-0.95%-1.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.04 -3.05 4.08 -23.98 -36.31
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 1.13 3.29 -3.07 -36.21 3.30K
Price-to-Free Cash Flow (P/FCF) Ratio
 -5.34 -5.91 -12.78 -105.77 -94.60
Price-to-Operating Cash Flow Ratio
 -2.24 -5.91 -12.78 -105.77 -94.60
Price-to-Earnings Growth (PEG) Ratio
 <0.01 <0.01 -0.02 0.44 1.44
Price-to-Fair Value
 1.13 3.29 -3.07 -36.21 3.30K
Enterprise Value Multiple
 -1.58 -2.15 -1.50 -24.41 -74.01
Enterprise Value
 2.12M 2.88M 985.72K 29.35M 136.30M
EV to EBITDA
 -1.58 -2.15 -1.50 -24.41 -74.01
EV to Sales
 0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 -3.26 -4.02 -13.73 -105.75 -94.41
EV to Operating Cash Flow
 -3.26 -4.02 -13.73 -105.74 -94.41
Tangible Book Value Per Share
 0.08 0.04 -0.02 >-0.01 <0.01
Shareholders’ Equity Per Share
 0.08 0.04 -0.02 >-0.01 <0.01
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 -0.53
Revenue Per Share
 0.00 0.00 0.00 0.00 0.00
Net Income Per Share
 -0.09 -0.04 0.01 >-0.01 -0.03
Tax Burden
 1.00 1.00 1.00 1.00 1.53
Interest Burden
 1.03 1.03 -0.34 1.02 1.34
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.55 0.52 -0.32 0.23 0.59
Currency in CAD